WEMXF yields 685.38% · PFE yields 6.13%● Live data
📍 WEMXF pulled ahead of the other in Year 1
Combined, WEMXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WEMXF + PFE for your $10,000?
Weimob Inc., an investment holding company, provides cloud-based commerce and marketing solutions in the People's Republic of China. It operates through Subscription Solutions, Merchant Solutions, and Digital Media segments. The Subscription Solutions segment provides cloud-hosted commerce and marketing SaaS products; customised software, such as ERP solutions; and other software related services, as well as WeiMall, Smart Retail, Smart Catering, Smart Hotel, Heading ERP, and others for e-commerce, retail, catering, hotel, local life, and other industries. The Merchant Solutions segment offers value-added services for merchants to meet merchants' online digital commerce and marketing needs, including assisting merchants to purchase online advertising traffic in various media platforms. The Digital Media segment provides advertisement placement services for merchants. The company was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.
Full WEMXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.